Cargando…

Elevated soluble urokinase plasminogen activator receptor serum levels indicate poor survival following transarterial chemoembolization therapy for hepatic malignancies: An exploratory analysis

BACKGROUND AND AIM: Transarterial chemoembolization (TACE) represents a standard of care for patients with intermediate‐stage hepatocellular carcinoma (HCC) or liver metastases. However, identification of the ideal candidates for TACE therapy remains challenging. The soluble urokinase plasminogen ac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Loosen, Sven H, Schulze‐Hagen, Max, Vucur, Mihael, Gorgulho, Joao, Paffenholz, Pia, Benz, Fabian, Mohr, Raphael, Demir, Münevver, Wree, Alexander, Kuhl, Christiane, Trautwein, Christian, Tacke, Frank, Bruners, Philipp, Luedde, Tom, Roderburg, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Publishing Asia Pty Ltd 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936623/ https://www.ncbi.nlm.nih.gov/pubmed/33732882 http://dx.doi.org/10.1002/jgh3.12501

Ejemplares similares

Macrophage migration inhibitory factor predicts an unfavorable outcome after transarterial chemoembolization for hepatic malignancies
por: Wirtz, Theresa H., et al.
Publicado: (2021)

Sarcopenia Is a Negative Prognostic Factor in Patients Undergoing Transarterial Chemoembolization (TACE) for Hepatic Malignancies
por: Loosen, Sven H., et al.
Publicado: (2019)

IL-6 and IL-8 Serum Levels Predict Tumor Response and Overall Survival after TACE for Primary and Secondary Hepatic Malignancies
por: Loosen, Sven H., et al.
Publicado: (2018)

Serum Levels of Soluble Urokinase Plasminogen Activator Receptor Predict Tumor Response and Outcome to Immune Checkpoint Inhibitor Therapy
por: Loosen, Sven H., et al.
Publicado: (2021)

Skeletal Muscle Composition Predicts Outcome in Critically Ill Patients
por: Loosen, Sven H., et al.
Publicado: (2020)

Circulating levels of soluble urokinase plasminogen activator receptor predict outcome after resection of biliary tract cancer
por: Loosen, Sven H., et al.
Publicado: (2020)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies
por: Özdirik, Burcin, et al.
Publicado: (2020)

A Combined Score of Circulating miRNAs Allows Outcome Prediction in Critically Ill Patients
por: Roderburg, Christoph, et al.
Publicado: (2019)

Serum levels of soluble urokinase plasminogen activator receptor (suPAR) predict outcome after resection of colorectal liver metastases
por: Loosen, Sven H., et al.
Publicado: (2018)

Serum Levels of Kisspeptin Are Elevated in Patients with Pancreatic Cancer
por: Loosen, Sven H., et al.
Publicado: (2019)

Serum Levels of miR-143 Predict Survival in Critically Ill Patients
por: Roderburg, Christoph, et al.
Publicado: (2019)

High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma
por: Loosen, Sven H, et al.
Publicado: (2019)

CT-based determination of excessive visceral adipose tissue is associated with an impaired survival in critically ill patients
por: Wirtz, Theresa H., et al.
Publicado: (2021)

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
por: Loosen, Sven H., et al.
Publicado: (2019)

Mouse models of hepatocarcinogenesis: What can we learn for the prevention of human hepatocellular carcinoma?
por: Vucur, Mihael, et al.
Publicado: (2010)

Serum levels of S100A6 are unaltered in patients with resectable cholangiocarcinoma
por: Loosen, Sven H., et al.
Publicado: (2016)

Elevated Serum Levels of Mixed Lineage Kinase Domain-Like Protein Predict Survival of Patients during Intensive Care Unit Treatment
por: Vucur, Mihael, et al.
Publicado: (2018)

Serum levels of bone sialoprotein correlate with portal pressure in patients with liver cirrhosis
por: Benz, Fabian, et al.
Publicado: (2020)

Elevated Omentin Serum Levels Predict Long-Term Survival in Critically Ill Patients
por: Luedde, Mark, et al.
Publicado: (2016)

Comparative Analysis of Circulating Biomarkers for Patients Undergoing Resection of Colorectal Liver Metastases
por: Loosen, Sven H., et al.
Publicado: (2021)

Levels of Circulating PD-L1 Are Decreased in Patients with Resectable Cholangiocarcinoma
por: Roderburg, Christoph, et al.
Publicado: (2021)

Circulating levels of microRNA193a-5p predict outcome in early stage hepatocellular carcinoma
por: Loosen, Sven H., et al.
Publicado: (2020)

Analysis of miR-29 Serum Levels in Patients with Neuroendocrine Tumors—Results from an Exploratory Study
por: Özdirik, Burcin, et al.
Publicado: (2020)

miR-155 Predicts Long-Term Mortality in Critically Ill Patients Younger than 65 Years
por: Tacke, Frank, et al.
Publicado: (2019)

Sarcopenia indicate poor survival in patients undergoing transarterial chemoembolization (TACE) for hepatic malignancies
por: Loosen, Sven H., et al.
Publicado: (2023)

Recent Trends and In-Hospital Mortality of Transarterial Chemoembolization (TACE) in Germany: A Systematic Analysis of Hospital Discharge Data between 2010 and 2019
por: Krieg, Sarah, et al.
Publicado: (2022)

Telomere Shortening in Peripheral Leukocytes Is Associated With Poor Survival in Cancer Patients Treated With Immune Checkpoint Inhibitor Therapy
por: Rolles, Benjamin, et al.
Publicado: (2021)

Circulating MicroRNA-150 Serum Levels Predict Survival in Patients with Critical Illness and Sepsis
por: Roderburg, Christoph, et al.
Publicado: (2013)

The Role of miRNAs in the Pathophysiology of Liver Diseases and Toxicity
por: Schueller, Florian, et al.
Publicado: (2018)

Elevated serum levels of bone sialoprotein during ICU treatment predict long-term mortality in critically ill patients
por: Luedde, Mark, et al.
Publicado: (2018)

Differential Roles of Tumor Necrosis Factor Ligand Superfamily Members as Biomarkers in Pancreatic Cancer
por: Pombeiro, Ines, et al.
Publicado: (2018)

Serum levels of kisspeptin are elevated in critically ill patients
por: Luedde, Mark, et al.
Publicado: (2018)

U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis
por: Benz, Fabian, et al.
Publicado: (2013)

Systemic treatment of hepatocellular carcinoma: from sorafenib to combination therapies
por: Roderburg, Christoph, et al.
Publicado: (2020)

The role of the innate immune system in the development and treatment of hepatocellular carcinoma
por: Roderburg, Christoph, et al.
Publicado: (2020)

Serum levels of miR-223 but not miR-21 are decreased in patients with neuroendocrine tumors
por: Hellberg, Teresa, et al.
Publicado: (2020)

Circulating MicroRNA-223 Serum Levels Do Not Predict Sepsis or Survival in Patients with Critical Illness
por: Benz, Fabian, et al.
Publicado: (2015)

Antibiotic therapy is associated with an increased incidence of cancer
por: Roderburg, Christoph, et al.
Publicado: (2022)

Decreased Bone Mineral Density Is a Predictor of Poor Survival in Critically Ill Patients
por: Schulze-Hagen, Maximilian F., et al.
Publicado: (2021)

An NF-kappaB- and IKK-Independent Function of NEMO Prevents Hepatocarcinogenesis by Suppressing Compensatory Liver Regeneration
por: Koppe, Christiane, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2bu01c0e7vorejfu1f76eqdgdh